Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O. O. Golik"'
Autor:
L. L. Popova, D. Yu. Konstantinov, Ye. A. Strebkova, S. Yu. Vasiliev, Ye. A. Konstantinova, O. O. Golik, Ye. S. Kindalova, A. F. Novikova
Publikováno v:
Журнал инфектологии, Vol 10, Iss 4, Pp 42-47 (2018)
Goal. Paritrapeprir / ritonavir / ombitasvir / dasabuvir on the clinical and laboratory parameters, including the subpopulation composition of lymphocytes, in patients with compensated cirrhosis in the outcome of chronic hepatitis C. Materials and me
Externí odkaz:
https://doaj.org/article/b30013393017475cbf404600edb6dc6f
Publikováno v:
Aspirantskiy Vestnik Povolzhiya. 19:85-90
The article is devoted to autoimmune diseases which are the actual problem of Hepatology. There is a number of open questions in the field of autoimmune liver diseases so far. The article presents the analysis of the clinical case of autoimmune hepat
Autor:
A. F. Novikova, O. O. Golik, G.V. Nedugov, L. L. Popova, A.A. Suzdaltsev, D. Yu. Konstantinov
Publikováno v:
Practical medicine. 17:40-43
Autor:
Ye. A. Strebkova, Ye. A. Konstantinova, L. L. Popova, S. Yu. Vasiliev, A. F. Novikova, D. Yu. Konstantinov, O. O. Golik, Ye. S. Kindalova
Publikováno v:
Žurnal Infektologii, Vol 10, Iss 4, Pp 42-47 (2018)
Goal. Paritrapeprir / ritonavir / ombitasvir / dasabuvir on the clinical and laboratory parameters, including thesubpopulation composition of lymphocytes, in patients with compensated cirrhosis in the outcome of chronic hepatitis C. Materials and met
Publikováno v:
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (6)
clarify the use in the treatment of CHC patients with cytopenia alternative treatment regimens, including leukocyte interferon alpha-alfaferon with ribavirin in combination with immuno-oriented roncoleukin with contraindications to the use of recombi